生物制剂(例如阿伦珠单抗、伊匹单抗、尼鲁单抗、派姆单抗)和细胞因子疗法(例如干扰素)可引起自身免疫性甲状腺疾病,包括无痛性甲状腺炎和 Graves 甲状腺功能亢进症。[39]Carella C, Mazziotti G, Amato G, et al. Clinical review 169: interferon-a-related thyroid disease: pathophysiological, epidemiological, and clinical aspects. J Clin Endocrinol Metab. 2004 Aug;89(8):3656-61.http://www.ncbi.nlm.nih.gov/pubmed/15292282?tool=bestpractice.com[40]Ahmadieh H, Salti I. Tyrosine kinase inhibitors induced thyroid dysfunction: a review of its incidence, pathophysiology, clinical relevance, and treatment. Biomed Res Int. 2013;2013:725410.http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824811/http://www.ncbi.nlm.nih.gov/pubmed/24282820?tool=bestpractice.com[41]Torino F, Barnabei A, Paragliola R, et al. Thyroid dysfunction as an unintended side effect of anticancer drugs. Thyroid. 2013 Nov;23(11):1345-66.http://www.ncbi.nlm.nih.gov/pubmed/23750887?tool=bestpractice.com